Sigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Sigilon Therapeutics

10/08/2021 12:54

* Sigilon Therapeutics Inc  SGTX.OQ  reported a quarterly
adjusted loss of 65 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 63 cents per share.
* Revenue was $2.70 million​;  analysts expected $3.10 million. 
* Sigilon Therapeutics Inc's reported EPS for the quarter was a
loss of 65 cents​.
* The mean earnings estimate of analysts had risen by about 5.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sigilon Therapeutics Inc shares had fallen by 53.4% this
quarter and lost 89.6% so far this year.
* The company reported a quarterly loss of $20.44 million.
* Wall Street's median 12-month price target for Sigilon
Therapeutics Inc is $29.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 11:54 a.m.  ​All
figures in US dollars unless otherwise stated